3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Ovarian Neoplasms
9
Neoplasms
9
Carcinoma, Non-Small-Cell Lung
9
Lung Neoplasms
7
Glioblastoma
7
Colorectal Neoplasms
6
Gliosarcoma
5
Neoplasm Metastasis
4
Colonic Neoplasms
4
Breast Neoplasms
4
Brain Neoplasms
4
Rectal Neoplasms
3
Fallopian Tube Neoplasms
3
Carcinoma, Renal Cell
3
Advanced Solid Tumor
3
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Solitary Fibrous Tumor, Pleural
2
Sarcoma, Alveolar Soft Part
2
Sarcoma
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Oligodendroglioma
2
Mesothelioma, Malignant
2
Melanoma
2
Leukemia, Myeloid, Acute
2
Carcinoma, Ovarian Epithelial
2
Breast Neoplasms, Male
2
Astrocytoma
2
Waldenstrom Macroglobulinemia
1
Interventions
cediranib
1
Leuprolide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Advanced Prostate Adenocarcinoma
×
cediranib
×
Clear all
NCT00502164
2011-01-21
AZD2171IL/0003
AstraZeneca
Phase 1
Completed
40 enrolled